Molecular Interactions of Arterial Hypertension in Its Target Organs

Joanna Kućmierz1, Weronika Frąk1, Ewelina Młynarska1

  • 1Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, ul. Żeromskiego 113, 90-549 Łódź, Poland.

Insights

Arterial hypertension (AH) significantly impacts cardiovascular health, affecting millions globally. This study explores molecular mechanisms behind AH and its damage to vital organs like the heart, kidneys, and brain.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Neurology

Background:

  • Arterial hypertension (AH) is a leading cause of cardiovascular disease mortality.
  • It affects 10-20% of adults, contributing to 5.8% of global deaths.
  • Key factors include renin-angiotensin-aldosterone system (RAAS) activation, oxidative stress, and inflammation.

Purpose of the Study:

  • To analyze molecular factors in the pathogenesis of arterial hypertension.
  • To investigate molecular interactions in hypertension-related target organ damage.
  • Focus on molecular mechanisms in the heart, blood vessels, brain, and kidneys.

Main Methods:

  • Review of molecular interactions in AH.
  • Analysis of matrix metalloproteinases (MMPs) in hypertensive organ damage.
  • Examination of the roles of the immune system, RAAS, oxidative stress, and inflammation.

Main Results:

  • AH accelerates damage to the heart, kidneys, brain, retina, and blood vessels.
  • Organ damage can manifest as coronary heart disease, cognitive impairment, retinopathy, and optic neuropathy.
  • Molecular pathways involving MMPs, immune responses, RAAS, and oxidative stress are implicated.

Conclusions:

  • Understanding molecular pathogenesis is crucial for managing AH and preventing target organ damage.
  • Targeting specific molecular pathways may offer therapeutic strategies.
  • Further research into these interactions is warranted for improved patient outcomes.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
180
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
1.9K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.8K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
4.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
106